Dr. Blank specializes in treating patients with gynecologic cancers, including ovarian, fallopian tube, primary peritoneal, uterine and cervical cancers, and in caring for women at increased risk of cancer. She has conducted extensive research on women’s cancers on topics including genetic predisposition to cancer (BRCA 1 and 2, Lynch Syndrome and others), novel treatment approaches, fertility preservation, survivorship, and quality of life. By serving on the Ovarian Committee of the NRG, Dr. Blank is involved in the development of NCI- sponsored practice-changing clinical trials, and she has been a principal investigator for multiple trials. She also collaborates with other researchers at the Tisch Cancer Institute on translational research in fields such as immunotherapy and DNA repair. Dr. Blank is broadly published in peer-reviewed journals and textbooks, and she frequently presents at national and international conferences on women’s gynecologic oncology issues.
Dr. Blank is the recipient of many honors and awards, including Castle Connolly Top Doctors, Super Doctors, and the Council on Resident Education in Obstetrics and Gynecology Teaching Award, among others. She serves on numerous boards and committees and is actively involved with many professional organizations, including the Society of Gynecologic Oncology, NRG Oncology, Foundation for Women’s Cancer, American College of Obstetricians and Gynecologists, and the American Society of Clinical Oncology.
Dr. Blank earned her medical degree from the University of California, San Diego, School of Medicine. She completed her residency in Obstetrics and Gynecology at the New York Hospital – Cornell Medical Center and a fellowship in Gynecologic Oncology at the University of Pennsylvania Medical Center.
